Grand Central Investment Group

Position in LLY — ELI LILLY & Co

CIK 1844893 TAMPA, FL

Position in LLY

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,174,566

+$637,631 QoQ

Shares Held

1,813

+8.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.40%

of 13F equity value

Holder Rank

#2,413

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Grand Central Investment Group holds $5,851,538 across 3 Drug Manufacturers - General names. LLY ranks #1 (37.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,813	$2,174,566
2	GILD	Gilead Sciences, Inc.	15,261	$1,928,074
3	ABBV	AbbVie Inc.	6,950	$1,748,898

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,174,566	1,813	+8.5%	Shares	Sole	2026-08-04
2026-03-31	$1,536,935	1,671	+8.6%	Shares	Sole	2026-04-23
2025-12-31	$1,653,932	1,539	—	Shares	Sole	2026-02-18
No filing history on record for this holder in this stock.